Kuros Biosciences AG (KURN):企業の財務・戦略的SWOT分析

◆英語タイトル:Kuros Biosciences AG (KURN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81908FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Kuros Biosciences AG (KURN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as well as on spinal fusion. Its pipeline of products are being developed for spinal fusion, fracture repair and as surgical sealants. Kuros Biosciences uses a synthetic matrix technology with reliable and pressure resistant, rapid closure of the damaged tissues. The company’s lead sealant product is Neuroseal. The company operates in Schlieren, Switzerland; Bilthoven, the Netherlands; Burlington, USA and in Konstanz, Germany. Kuros Biosciences is headquartered in Schlieren, Switzerland.

Kuros Biosciences AG Key Recent Developments

Aug 12,2020: Kuros Biosciences reports results for first half 2020
Mar 26,2020: Kuros Biosciences reports results for the full year 2019
Dec 03,2019: Kuros announces final result of Capital Increase – total gross proceeds of CHF 12.5 million raised
Aug 20,2019: Kuros Biosciences reports results for first half 2019
Jul 24,2019: Kuros announces Gerhard Ries is stepping down as Board member

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Kuros Biosciences AG – Key Facts
Kuros Biosciences AG – Key Employees
Kuros Biosciences AG – Key Employee Biographies
Kuros Biosciences AG – Major Products and Services
Kuros Biosciences AG – History
Kuros Biosciences AG – Company Statement
Kuros Biosciences AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Kuros Biosciences AG – Business Description
Geographical Segment: Other
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: United States of America
Performance
Kuros Biosciences AG – SWOT Analysis
SWOT Analysis – Overview
Kuros Biosciences AG – Strengths
Kuros Biosciences AG – Weaknesses
Kuros Biosciences AG – Opportunities
Kuros Biosciences AG – Threats
Kuros Biosciences AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Kuros Biosciences AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 12, 2020: Kuros Biosciences reports results for first half 2020
Mar 26, 2020: Kuros Biosciences reports results for the full year 2019
Dec 03, 2019: Kuros announces final result of Capital Increase – total gross proceeds of CHF 12.5 million raised
Aug 20, 2019: Kuros Biosciences reports results for first half 2019
Jul 24, 2019: Kuros announces Gerhard Ries is stepping down as Board member
Apr 30, 2019: Kuros Biosciences to propose re-appointment of chairman and board members at Annual General Meeting
Apr 12, 2019: Kuros Biosciences reports results for the full year 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Kuros Biosciences AG, Key Facts
Kuros Biosciences AG, Key Employees
Kuros Biosciences AG, Key Employee Biographies
Kuros Biosciences AG, Major Products and Services
Kuros Biosciences AG, History
Kuros Biosciences AG, Subsidiaries
Kuros Biosciences AG, Key Competitors
Kuros Biosciences AG, Ratios based on current share price
Kuros Biosciences AG, Annual Ratios
Kuros Biosciences AG, Annual Ratios (Cont...1)
Kuros Biosciences AG, Interim Ratios
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kuros Biosciences AG, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Kuros Biosciences AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Kuros Biosciences AG (KURN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • North Eastern Electric Power Corporation Ltd:発電所・企業SWOT分析
    North Eastern Electric Power Corporation Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • J.E. Dunn Construction Group, Inc.:企業の戦略的SWOT分析
    J.E. Dunn Construction Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Katara Hospitality:企業の戦略・SWOT・財務情報
    Katara Hospitality - Strategy, SWOT and Corporate Finance Report Summary Katara Hospitality - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer an …
  • Kelly Services, Inc.:企業の戦略・SWOT・財務情報
    Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kelly Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • EBS Technologies GmbH:医療機器:M&Aディール及び事業提携情報
    Summary EBS Technologies GmbH (EBS) is a medical device company that develops stimulation system for visual field effect. The company offers Eyetronic Therapy, which has been developed for patients suffering from a progressive visual field loss due to glaucoma and other diseases of the optic nerve. …
  • APL Co Pte Ltd:企業の戦略的SWOT分析
    APL Co Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Michael Baker International LLC:企業の戦略・SWOT・財務情報
    Michael Baker International LLC - Strategy, SWOT and Corporate Finance Report Summary Michael Baker International LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Senhwa Biosciences Inc (6492)-製薬・医療分野:企業M&A・提携分析
    Summary Senhwa Biosciences Inc (Senhwa) is a drug development company that develops small molecule drugs for the treatment of cancer. The company’s products include CX-5461 and CX-4945. Its CX-5461 is a p53 activating Pol I inhibitor and anticancer compound for treating hematological malignancies. S …
  • SFL Corp Ltd (SFL):企業の財務・戦略的SWOT分析
    Summary SFL Corp Ltd (SFL) is engaged in providing bulker, tanker, container, and offshore solutions. The company offers fleet of vessels such as crude oil tankers for ultra-deep water semi-submersible, dry bulk carriers and drilling rigs, among others. In addition, it also operates car carriers, of …
  • State Atomic Energy Corporation Rosatom:企業の戦略的SWOT分析
    State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • ACB Securities Co Ltd:企業の戦略的SWOT分析
    ACB Securities Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SAS Institute Inc.:戦略・SWOT・企業財務分析
    SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report Summary SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ResCare, Inc.:企業の戦略・SWOT・財務情報
    ResCare, Inc. - Strategy, SWOT and Corporate Finance Report Summary ResCare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hyperstone GmbH:企業の戦略的SWOT分析
    Hyperstone GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Owensboro Municipal Utilities:発電所・企業SWOT分析
    Owensboro Municipal Utilities - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Bright Horizons Family Solutions LLC (BFAM):企業の財務・戦略的SWOT分析
    Summary Bright Horizons Family Solutions LLC (Bright Horizons) is a provider of educational advisory services and child care services. The company offers curriculum and programs including early education and preschool, back-up child and adult care programs, infant care, toddler care, college coach, …
  • Citizens Energy Group:企業の戦略的SWOT分析
    Citizens Energy Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆